التفاصيل البيبلوغرافية
| العنوان: |
Novel Epigenetic Modifiers of Histones Presenting Potent Inhibitory Effects on Adenoid Cystic Carcinoma Stemness and Invasive Properties. |
| المؤلفون: |
Pina, Paulo S. S.1,2 (AUTHOR) ps.souzapina@alumni.usp.br, Jang, Yeejin1 (AUTHOR) stellajang23@gmail.com, Emerick, Carolina1,3 (AUTHOR) carolina.emerick@gmail.com, Scarini, João Figueira1,3 (AUTHOR) scarinij@gmail.com, Sousa, Suzana C. O. M.2 (AUTHOR), Squarize, Cristiane H.1,4 (AUTHOR) csquariz@umich.edu, Castilho, Rogerio M.1,4 (AUTHOR) rcastilh@umich.edu |
| المصدر: |
International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1646. 15p. |
| مصطلحات موضوعية: |
*ADENOID cystic carcinoma, *CELL migration inhibition, *HISTONES, *CANCER stem cells, *EPIGENETICS, *CELL migration, *HIGH throughput screening (Drug development), *BREAST |
| مستخلص: |
Adenoid cystic carcinoma (ACC) is a rare neoplasm known for its indolent clinical course, risk of perineural invasion, and late onset of distant metastasis. Due to the scarcity of samples and the tumor's rarity, progress in developing effective treatments has been historically limited. To tackle this issue, a high-throughput screening of epigenetic drugs was conducted to identify compounds capable of disrupting the invasive properties of the tumor and its cancer stem cells (CSCs). ACC cells were screened for changes in tumor viability, chromatin decondensation, Snail inhibition along tumor migration, and disruption of cancer stem cells. Seven compounds showed potential clinical interest, and further validation showed that Scriptaid emerged as a promising candidate for treating ACC invasion. Scriptaid demonstrated a favorable cellular toxicity index, effectively inhibited Snail expression, induced hyperacetylation of histone, reduced cell migration, and effectively disrupted tumorspheres. Additionally, LMK235 displayed encouraging results in four out of five validation assays, further highlighting its potential in combating tumor invasion in ACC. By targeting the invasive properties of the tumor and CSCs, Scriptaid and LMK235 hold promise as potential treatments for ACC, with the potential to improve patient outcomes and pave the way for further research in this critical area. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder